External NordiQC Assessment Reports
GenomeMe participates in the NordiQC international quality assessment testing program for clinical IHC. Access the individual NordiQC assessment reports for each of the antibodies tested:
| ANTIGEN | CLONE | ASSESSMENT | RUN # |
|---|---|---|---|
| Calretinin | IHC523 | Optimal | 64 2022 |
| CD15 | IHC527 | Optimal | 61 2021 |
| CD31 | IHC031 | Optimal | 62 2021 |
| CD56 | IHC066 | Optimal | 61 2021, 64 2022 |
| CDX-2 | IHC302 | Good | 61 2021 |
| Cytokeratin 5/6 | IHC556 | Good | 63 2021 |
| Estrogen Receptor | IHC423 | Optimal | B32 2021, B33 2022 |
| HER2/neu | IHC042 | Optimal | B32 2021, B33 2022 |
| MSH6 | IHC026 | Optimal | 61 2021 |
| p63 | IHC063 | Good | 61 2021 |
| PAX-8 | IHC048 | Optimal | 62 2021, 64 2022 |
| PMS2 | IHC422 | Good | 62 2021 |
| Progesterone Receptor | IHC751 | Optimal | B31 2021, B33 2022 |